中文摘要：

目的了解合肥市某社区中老年人群代谢综合征（MS）的患病情况与流行特征.方法采用整群随机抽样的方法,对合肥市某社区内2 860 位40 岁及以上常住居民进行问卷调查、体格检查和实验室检查.按照国际糖尿病联盟诊断标准（IDF）对MS 进行诊断.结果调查对象共调查2 860 人,男性1 093 人（38.22% ）,女性1 767 人（61.78% ）,平均年龄（56.38 ± 10.8）岁,MS 患病率为34.55% ,标化患病率为33.73% ,女性（39.7% ）明显高于男性（26.2% ）,不同年龄段、不同文化程度、不同婚姻状况、不同居住情况调查对象间MS 患病率不同.MS 各组分患病率在25.8% ～ 56.4% ,在中心性肥胖的基础上,合并两项指标异常的有499 人（17.4% ）,合并3 项指标异常的有369 人（12.9% ）,五项全部异常的有120 人（4.2% ）,MS 异常指标组合中以中心性肥胖合并低高密度脂蛋白（HDL）和血压异常的患病率最高（18.7% ）,除了合并三酰甘油和血糖异常的患病率男女间差异无统计学意义外,其他5 个组合的患病率女性均高于男性,差异有统计学意义（P 〈0.05）.结论该社区40 岁及以上居民MS 患病率较高,女性较男性患病率高,合并二项及以上代谢异常的比例较高.

英文摘要：

Objective To understand the prevalence and epidemiologic characteristics of metabolic syndrome (MS)among mid -aged residents in Hefei city. Methods The stratified cluster random sampling was used to select 2860 residents aged > 40 years. They were given questionnaire survey,physician check-up and laboratory test. The MS was diagnosed according to the diagnostic criteria of International Diabetes Federation (IDF). Results A total of 2860 residents were interviewed with questionnaire,including 1093 men(38. 22%)and 1767 women(61. 78%). The average age was 56. 38 ± 10. 8,the MS prevalence was 34. 55% and the standardized prevalence of MS was 33. 73%,and the prevalence of female(39. 7%)was significantly higher than that of male(26. 2%). The MS prevalence changed among different ages,different education degree,different marital status and different living conditions. The prevalence of MS components was 25. 8% ~ 56. 4% . On the basis of central obesity,499(17. 4%),369(12. 9%)and 120(4. 2%)people were found abnormal with two, three and four components respectively. The combination of central obesity and low high density lipoprotein cholesterol with hypertension ac-counted for 18. 7% . The prevalence of combination of central obesity and high TG and high glucose in female was higher than that in male ex-cept other combinations. Conclusion The MS prevalence is high in Hefei,especially in women residents. A large proportion of the people have two or more kinds of metabolic abnormality.